Month: April 2020

Posted on

Motley Fool Money - Chipotle’s Special Sauce, Netflix’s Big Number, DraftKings’ Latest Bet

More than 4.4 million Americans file for unemployment as the total number of unemployed climbs to 26 million. Netflix adds 16 million subscribers for the quarter. Verizon loses subscribers and withdraws guidance. Chipotle gets a big boost from digital sales. DraftKings makes its Wall Street debut. Snap surges on surprising growth. Coca-Cola falls on concerns over declining volume. And Domino’s delivers. Motley Fool analysts Ron Gross and Jason Moser discuss those stories and share a couple of stocks on their radar: Masimo and Roku. Plus, Time Value of Money Fund manager Michael Shearn talks about what he looks for in leadership and shares some of his favorite stocks.

Learn more about your ad choices. Visit megaphone.fm/adchoices

Posted on

Stuff They Don't Want You To Know - Your News Agency or the CIA: The Story of Operation Mockingbird

Propaganda has always been a powerful tool, and humanity's recent technological innovations have only amplified its reach. Long-standing laws in the US were meant to prevent US propaganda for foreign audiences from reaching the domestic population, but over time those laws have been eroded... and, as it turns out, Uncle Sam was secretly pushing propaganda on the people for years beforehand. Tune in to learn more about Operation Mockingbird.

Learn more about your ad-choices at https://www.iheartpodcastnetwork.com

They don't want you to read our book.: https://static.macmillan.com/static/fib/stuff-you-should-read/

See omnystudio.com/listener for privacy information.

array(3) { [0]=> string(150) "https://www.omnycontent.com/d/programs/e73c998e-6e60-432f-8610-ae210140c5b1/2e824128-fbd5-4c9e-9a57-ae2f0056b0c4/image.jpg?t=1749831085&size=Large" [1]=> string(10) "image/jpeg" [2]=> int(0) }
Posted on

The Intelligence from The Economist - Unsteady states: America’s piecemeal reopening

Some governors are co-ordinating mutual lockdown plans, others are already reopening their states. That haphazardness bodes ill in the absence of widespread testing and tracing. The pandemic is kicking an industry that was already down: newspapers’ readerships are up, but profits are through the floor. And, reflecting on the life of a saintly obstetric surgeon in Ethiopia. For full access to print, digital and audio editions of The Economist, subscribe here www.economist.com/radiooffer
Posted on

Strict Scrutiny - Podapalooza Live Event

We'll be hosting a live Q&A event as part of podapalooza this Sunday (April 26) at 1 PM ET!

Get tickets for STRICT SCRUTINY LIVE – The Bad Decisions Tour 2025! 

  • 6/12 – NYC
  • 10/4 – Chicago

Learn more: http://crooked.com/events

Order your copy of Leah's book, Lawless: How the Supreme Court Runs on Conservative Grievance, Fringe Theories, and Bad Vibes

Follow us on Instagram, Threads, and Bluesky

Posted on

The Best One Yet - “A tale of 2 Remdesivir trials” — Raytheon’s nuclear-tipped missiles. Unilever is an economic mirror. Gilead’s 2nd COVID trial.

Ben & Jerry’s owner Unilever announced earnings that reflect the product hoarding and usage habits of the entire world (we know you’re not showering). Raytheon snags a nuclear-tipped stealth cruise missile deal that reveals what the defense industry is facing in a corona-conomy. And Gilead’s COVID-19 treatment just had disappointing results from a leaked report — markets react accordingly. Learn more about your ad choices. Visit podcastchoices.com/adchoices See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
Posted on

What Next | Daily News and Analysis - TBD | Can We Really Make a Safe Vaccine in 18 Months?

There are over 60 vaccines for the coronavirus currently in development. Four of them are already being tested in humans. As researchers move at breakneck speed to find a vaccine, they’re debating breaking (or at least bending) the rules that ensure the end product is safe.


How do we balance speed with safety in the rush to develop a vaccine?


Guest: Dr. Timothy Lahey, an infectious diseases doctor, ethicist, and vaccine researcher at the University of Vermont Medical Center.

Learn more about your ad choices. Visit megaphone.fm/adchoices